Gesynta Pharma (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Registration number:
559103-6628
Business model:
B2B
Investors:
we tracked 3 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Gesynta Pharma AB leverages expertise in arachidonic acid research to explore niche indications in chronic inflammation for mPGES-1 inhibitors.

Companies with similar profile to Gesynta Pharma:

CompanyCriteria
Sweden Trialbee
56%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Sweden Athera
56%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • At least one other investor: Karolinska Development
Sweden AMRA
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Finland Forendo Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
Sweden Gradientech
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden Airsonett
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Norway Smartfish
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden InDex Pharmaceuticals
35%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden BoneSupport
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden OxThera
35%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden Quretech Bio
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Mantex
34%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Sweden AttgeNO
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Norway Vaccibody
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Denmark NMD Pharma
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Norway Fürst Medisinsk Laboratorium
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Ilya Pharma
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden ITBMed
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Vironova
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Burt
34%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD